Patents by Inventor Doreen JAHN

Doreen JAHN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Eukaryotic expression vectors comprising regulatory elements of the globin gene clusters
    Patent number: 10184135
    Abstract: The present invention pertains to the field of recombinant protein production. Novel expression cassettes comprising elements of the human globin gene clusters are provided which show enhanced expression rates of proteins or polypeptides of interest.
    Type: Grant
    Filed: March 30, 2016
    Date of Patent: January 22, 2019
    Assignee: Glycotope GmbH
    Inventors: Steffen Goletz, Doreen Jahn, Antje Danielczyk
  • HETEROMERS COMPRISING ANTIBODY DOMAIN FUSION PROTEINS
    Publication number: 20180216093
    Abstract: The present invention pertains to fusion constructs of dimeric proteins, wherein the portions of the protein are fused to either to the CH1 domain of the CL domain of an antibody. These fusion constructs improve stability, solubility, circulation half-life and production yield of the dimeric protein.
    Type: Application
    Filed: August 5, 2016
    Publication date: August 2, 2018
    Inventors: Steffen GOLETZ, Doreen JAHN
  • EUKARYOTIC EXPRESSION VECTORS COMPRISING REGULATORY ELEMENTS OF THE GLOBIN GENE CLUSTERS
    Publication number: 20180094279
    Abstract: The present invention pertains to the field of recombinant protein production. Novel expression cassettes comprising elements of the human globin gene clusters are provided which show enhanced expression rates of proteins or polypeptides of interest.
    Type: Application
    Filed: March 30, 2016
    Publication date: April 5, 2018
    Applicant: Glycotope GmbH
    Inventors: Steffen GOLETZ, Doreen JAHN, Antje DANIELCZYK
  • PEPTIDES FOR ENHANCING PROTEIN EXPRESSION
    Publication number: 20150353959
    Abstract: The present invention pertains to the field of recombinant protein production. Novel peptides derived from the extracellular region of a glycophorin protein are provided which enhance the expression rate of proteins or peptides of interest when expressed as fusion protein together with said novel peptides.
    Type: Application
    Filed: January 17, 2014
    Publication date: December 10, 2015
    Inventors: Steffen GOLETZ, Antje DANIELCZYK, Doreen JAHN